U.S. health officials urge use of HIV pill for at-risk individuals

U.S. health officials on Wednesday issued new recommendations urging healthcare workers to consider offering an HIV prevention pill to healthy individuals who are at substantial risk for HIV infection. The guidelines, issued by the U.S. Centers for Disease Control and Prevention and the U.S. Public Health Service, involve the use of pre-exposure prophylaxis or PrEP, a strategy in which at-risk individuals take a daily dose of an antiretroviral drug to reduce their risk of HIV infection. The strategy builds on a landmark 2010 study that found Gilead Sciences Inc’s Truvada – a pill already widely used to treat the human immunodeficiency virus – was more than 90 percent effective at preventing HIV infections among test subjects who took the drug as prescribed.
Sexual Health News Headlines – Yahoo! News